Our Strategic Pillars
31 new doctors have joined Monash IVF Group in Australia and South-East Asia, setting up a foundation for continued growth into FY23 and beyond.
Continually focusing on our patient experience.
Monash IVF Group invests in innovative technology and research to ensure that we continue to provide market leading success rates for our patients.
In FY22, Monash IVF Group further expanded in South-East Asia (SEA) building the total portfolio of clinics in the region to 5.
The Group is proud to be recognised in 2022 as one of 11 organisations who were newly awarded the WGEA Employer of Choice citation.
The Hybrid Work Model will continue to be the norm for the next few years and our processes, systems and spaces are being redesigned to reflect the current reality.
Brand & Marketing
As a purpose led organisation, we believe we have a role to play in creating a societal shift in how people think and behave in relation to their fertility.
Monash IVF Group has continued to invest in best-in-class clinical facilities and technology, setting the foundations for growth.
ESG (Environment, Social & Governance)
Global challenges, such as climate risk, increased regulatory pressures, social and demographic shifts and privacy and data security concerns, represent new or increasing risks for organisations.
Monash IVF’s mission to help bring life to the world extends beyond treatment for infertility. Our expertise and innovative mindset are essential for navigating new areas of clinical care including genetics, donor treatment and elective fertility preservation.
We are pleased to have delivered a strong financial performance in FY22 against a backdrop of attractive Industry fundamentals that saw Australian Reproductive Services in Australia reach record levels.